Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
Published: March 7th 2021 | Updated:
Letter: BPH guidelines may ignore FDA, insurance criteria
Published: May 12th 2020 | Updated:

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones

Practical guide to female pelvic organ–sparing radical cystectomy

CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction

Targeting BCG resistance in high-risk NMIBC

Lina Posada Calderon, MD, provides insights on germline BAP1–associated renal cell carcinoma